Rationale: Measuring disease extent and progression of systemic sclerosis–associated
interstitial lung disease (SSc-ILD) is challenging, with recent studies suggesting potential …

Quantitative high resolution computed tomography (HRCT) may objectively assess systemic
sclerosis (SSc)-interstitial lung disease (ILD) extent, using three basic densitometric …

Background To evaluate usability of slice-reduced sequential computed tomography (CT)
compared to standard high-resolution CT (HRCT) in patients with systemic sclerosis (SSc) …

Objectives To evaluate interstitial lung disease associated with systemic sclerosis (SSc-ILD)
and its changes during treatment by using quantitative analysis (QA) compared to semi …

Background: Interstitial lung disease (ILD) is a common complication in patients with
systemic sclerosis (SSc), and its diagnosis contributes to early treatment decisions …

Objective Although interstitial lung disease (ILD) is a major cause of morbidity and mortality
in systemic sclerosis (SSc), its prognostication remains challenging. Given that CT …

Systemic sclerosis (SSc) is a systemic autoimmune disease affecting multiple organ
systems, including the lungs. Interstitial lung disease (ILD) is the leading cause of death in …

Objectives To compare the previously defined six different histogram-based quantitative
lung assessment (QLA) methods on high-resolution CT (HRCT) in patients with systemic …

Trials in systemic sclerosis-associated interstitial lung disease (SSc-ILD) typically use forced
vital capacity (FVC) as the primary end-point [1, 2]; however, pulmonary function tests have …

Introduction Interstitial lung disease occurs frequently in patients with systemic sclerosis
(SSc). Quantitative computed tomography (CT) densitometry using the percentile density …